Europe Molecular Diagnostic Market

Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products (Polymerase chain reaction, Non-amplified tests, and Isothermal nucleic acid amplification technology; Hospitals, Public health laboratories, and Others) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2015 - 2023

  • Rep Id : TMRGL10505
  • Published On : Apr 2016
  • No. of Pages : 64
  • Category : Healthcare

Table of Content

Chapter 1 Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary

Chapter 3 Europe Molecular Diagnostic Market for Group A Streptococcus (GAS) NA Tests Market Overview
3.1 Introduction
3.2 Market Dynamics
     3.2.1 Drivers
     3.2.2 Restraints
     3.2.3 Opportunities
3.3 Porter’s Five Forces Analysis 
     3.3.1 Bargaining Power of Suppliers
     3.3.2 Bargaining Power of Buyers
     3.3.3 Threat of New Entrants
     3.3.4 Threat of Substitutes
     3.3.5 Competitive Rivalry
3.4 Patient Pool Analysis 
     3.4.1 Mild illness (Acute pharyngitis)
     3.4.2 Severe illness (e.g. Pneumonia, necrotizing fasciitis, etc.)
3.5 Market Attractiveness Analysis: Europe Molecular Diagnostic Market for Group A Streptococcus (GAS) NA Tests Market, by Top Countries
3.6 Competitive Landscape, by Key Players, 2014

Chapter 4 Europe Molecular Diagnostic Market for Group A Streptococcus (GAS) NA Tests Market Revenue (US$ Mn), by Type of Test Technique, 2013–2023
4.1 Overview
4.2 Isothermal nucleic acid amplification technology (iNAT)
4.3 Polymerase chain reaction
4.4 Non-Amplified Tests

Chapter 5 Europe Molecular Diagnostic Market for Group A Streptococcus (GAS) NA Tests Market Revenue (US$ Mn), by End-user, 2013–2023 
5.1 Overview
5.2 Hospitals
5.3 Public Health Laboratories
5.4 Others (Referenced and Clinical Laboratories)

Chapter 6 Europe Molecular Diagnostic Market for Group A Streptococcus (GAS) NA Tests Market Revenue (US$ Mn), by Major Regions and Countries, 2013–2023 
6.1 Overview
6.2 Northern Europe
     6.2.1 Ireland 
     6.2.2 Norway
     6.2.3 Sweden
     6.2.4 United Kingdom of Great Britain and Northern Ireland
     6.2.5 Rest of Central Europe
6.3 Eastern Europe
     6.3.1 Ukraine
     6.3.2 Poland 
     6.3.3 Czech Republic
     6.3.4 Russian Federation
     6.3.5 Rest of Eastern Europe
6.4 Western Europe
     6.4.1 France
     6.4.2 Germany
     6.4.3 Austria
     6.4.4 Rest of Western Europe
6.5 Southern Europe
     6.5.1 Italy
     6.5.2 Spain
     6.5.3 Portugal
     6.5.4 Rest of Southern Europe
6.6 Rest of Europe (including Scandinavia, Mediterranean Europe, Azerbaijan, etc.)

Chapter 7 Current Trends and Historical Snapshot

Chapter 8 Company Profiles
8.1 Alere Inc.
     8.1.1 Company Overview
     8.1.2 Financial Overview
     8.1.3 Product Portfolio
     8.1.4 Business Strategies
     8.1.5 Recent Developments
8.2 Focus Diagnostics, Inc. 
8.3 F. Hoffmann-La Roche Ltd.
8.4 Hologic, Inc. 
8.5 Meridian Bioscience, Inc.
8.6 Nanosphere
8.7 Quidel Corporation

.